Human Vaccination Market 2020

The global market size for human vaccines is anticipated to observe tremendous growth projections during 2019 – 2025.

The prominent factors that are expected to contribute to the growth of the global human vaccines market during the forecast period:

  • Increased Disease Awareness
  • Approval/launches of the New Vaccines
  • Rising focus on immunization programs
  • Increasing government support for the vaccine development

Highlighted with 35 tables and 140 figures, this 310-page report “Global Human Vaccines Market Size, Trends, Opportunities and Growth Potential” provides a comprehensive analysis of the fast-evolving, high-growth global human vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the global human vaccines market. The report provides historical market data for 2015 – 2018, and forecasts from 2019 till 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025. The report provides in-depth analysis, information and revenue according to segments such as disease indications, end-users, leading vaccines, and companies from 2015 to 2018 and forecasts to 2025. A comprehensive analysis has been done on market share with percentage of all the segments.

Key trends in terms of collaboration, partnerships, merger & acquisition, distribution, exclusive and licensing agreement are analyzed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2025.

The report concludes with the profiles of the key players in the global human vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, vaccines revenue analysis and recent development.

Other emerging players are making novel technology-based vaccines which are likely to affect the market share during the forecast period. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology and diseases which are seeing vaccines development activity such as infectious diseases, non-infectious diseases, emerging pathogens, and recent development.

Key Topics Covered in the Report:

  • The Market Size of the Global Human Vaccines Market
  • The Market Size of the Global Pediatric Vaccines Market
  • The Market Size of the Global Adult Vaccines Market
  • The Market Size of the 42 Leading Vaccines
  • The Market Size of the Pneumococcal Disease, Diphtheria, Tetanus and Pertussis (DTP), Influenza, Human Papillomavirus (HPV), Meningococcal, Hepatitis, Measles, Mumps, and Rubella (MMR), Rotavirus, Varicella.
  • Thoroughly Evaluates Market Share of the Segments such as Disease Indications, End Users, Leading Vaccines, and Companies
  • Investigates the Key Growth Drivers and Restraints of the Global Human Vaccines Market
  • Provides Key Trends with Respect to Collaboration, Partnerships, Merger & Acquisition, Distribution, Exclusive and Licensing Agreement
  • A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development
  • An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Platform Technology, and Recent Development

Detailed Segmentation:

Global Human Vaccines Market, By Disease Indication

  • Influenza
  • Meningococcal
  • Hepatitis
  • Rotavirus
  • Varicella
  • Pneumococcal Disease
  • Diphtheria, Tetanus, and Pertussis (DTP)
  • Measles, Mumps, and Rubella (MMR)
  • Human Papillomavirus (HPV)

Global Human Vaccines Market, By End User

  • Pediatric Vaccines
  • Adult Vaccines

Global Human Vaccines Market, By Leading Vaccines

  • Prevnar / Prevnar 13
  • Gardasil / Gardasil 9
  • Vaxigrip
  • Fluzone
  • Flublok
  • Varivax
  • Menactra
  • Proquad
  • Pneumovax 23
  • Fluarix/FluLaval
  • Havrix/Twinrix/Engerix–B
  • Priorix, Priorix Tetra, Varilrix
  • M–M–R II
  • Adacel
  • Boostrix
  • Bexsero
  • Menveo
  • Cervarix
  • Trumenba
  • Shingrix
  • Pentacel, Pentaxim, Imovax, Hexaxim
  • Rotateq
  • Zostavax
  • Rotarix
  • Synflorix
  • Pediarix, Infanrix
  • Ticovac
  • Biken Ha
  • Tetrabik
  • Mearubik
  • Varicella (MTP)
  • Jebik V
  • Flumist/Fluenz
  • Bio Thrax
  • Dukoral
  • Ixiaro
  • In Live
  • HeaLive
  • BiLive
  • Anflu
  • EasySix
  • Imvamune

Global Human Vaccines Market, By Key Players

  • Sanofi Pasteur
  • GlaxoSmithKline (GSK)
  • Merck
  • Pfizer
  • AstraZeneca
  • Mitsubishi Tanabe Pharma
  • Emergent Biosolutions
  • Astellas Pharma Inc.
  • Valneva
  • Seqirus
  • Bavarian Nordic
  • Sinovac
  • Panacea Biotec
  • Bharat Biotech
  • Serum Institute of India
  • Biological E. Limited

Global Human Vaccines Market, By Emerging Players

  • Vaccitech
  • Janssen (Johnson & Johnson)
  • Novavax
  • VBI Vaccines
  • GeoVax
  • Moderna Inc
  • Biondvax
  • Integrated Biotherapeutics Inc
  • GeneOne Life Science
  • Profectus BioSciences
  • Pneumagen
  • Themis Bioscience
  • Xeme Biopharma Inc
  • Altimmune
  • Pfenex Inc
  • Northwest Biotherapeutics
  • OncBioMune Pharmaceuticals

The Report Helps Answer the Following Questions:

  • What is the current size of the overall global human vaccines market? How much will this market be worth from 2019 to 2025?
  • What are the market shares of the leading segments of the global human vaccines market in 2018?
  • What are the main segments within the overall human vaccines market? How much will each of these segments be worth for the period 2015 to 2025?
  • What are the main drivers and restraints in the global human vaccines market?
  • What are the leading vaccines? What are their revenue potentials to 2025?
  • What are the major deals happenings in the global vaccines market?
  • Who are the leading companies and what are their activities, revenue, recent developments, and prospects?
  • What are some of the most prominent human vaccines currently in development? What are their activities, platform technology, and recent developments?
  • What are new disease areas which the vaccines companies are exploring?

The report is readily available and can be dispatched immediately after payment confirmation.

More Information @ https://dpiresearch.com/reports/global-human-vaccines-market-size-trends-opportunities-and-growth-potential/

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

About Us:

DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals. We deliver a wide range of cutting-edge research solutions that help organizations in making better decisions of the business to business needs.

DPI Research provides a high standard of business research reports to the clients across industry verticals comprising Life Sciences, Information Technology, Telecom & Internet, Food Beverages & Agriculture, Travel & Tourism, Consumer Goods & Retail, Education and Social Sciences. We are committed to using advanced analytical tools and methodologies to help clients with crucial industry information for decision making.

DPI Research approaches for business research led by a team of dynamic industry experts. DPI Research provides real insight for effective decisions to help business with the help of current source and accurate data available in the market. DPI Research reaches across the globe with global standards from established markets in North America and Europe to emerging markets in South America, Asia-Pacific, Middle East, and Africa to provide the best business solutions.

Contact Us:
Maria Rai
Head of Business Development
DPI Research | Web:   https://dpiresearch.com
Direct Line: +91-766-764-8693
E-mail: sales@dpiresearch.com

Business Funding South Africa Rebranded to Bufsa Group:

After many years under the forwarding thinking leadership of Hein Rautenbach, Business Funding South Africa has made massive strides in the Financial Industry. From Accounting and Tax services to Long and Short Term Insurance, Business Funding South Africa has stood the test of time. With this in mind, the company has expanded into all sectors of the financial industry and with growth comes innovation. Therefore the company has decided to rebrand itself as Bufsa Group under leadership of Chairperson Hein Rautenbach and CEO Christiaan Laubscher.

 

With an overhaul of the business’s branding, a new website was developed to show our clients, we mean business. Showing a wide array of services Bufsa Group covers, the new website, showcases the company’s vision as well as providing all the necessary information one needs to see when looking for a new accountant, tax consultant or insurance broker. The website is aesthetically appealing as well as functional and easy to navigate. 

 

The “Our Team” page of the website allows for you the user to see who exactly you are dealing with, whether locally in Cape Town or Nationally, Bufsa Group provides full transparency on all it’s dealings, with an open book policy for their clients’ peace of mind. Bufsa Group is on its way to becoming one of South Africa’s top Financial Services providers. Don’t forget to check out Bufsa Group’s monthly Blog to keep up with the latest industry news, financial tips and newest product offerings. Whether it be for personal or business needs, Bufsa Group is knowledgeable in all things accounting and tax-related and provides custom cost analysis based on your personal portfolio for all insurance services.

Don’t hesitate, when it comes to your financial well-being. Visit us at www.bufsagroup.co.za for more information, alternatively, feel free to contact us on info@bufsagroup.co.za or give us a call on 021 855 1387.

Worldwide Influenza Vaccines Market Size and Forecast

DPI Research has recently published a comprehensive analysis titled “Worldwide Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027” to its intensifying repository. The main objective of the statistical report is to present a 360-degree overview of the competitive landscape across  regions and countries such as United States,  Europe and Asia-Pacific etc. The erudite report examines some of the significant exploratory techniques such as primary and secondary research.

Worldwide Influenza Vaccines Market 2020 – 2027 research report provides information regarding market size, share, cost structure, trends, growth, capacity, revenue and Forecast 2027. This report also includes the inclusive and comprehensive study of the Influenza Market with all its aspects influencing the growth of the market. This report gives exhaustive quantitative analyses of the influenza market industry and delivers data for making strategies to surge the market growth and effectiveness.

Highlighted with 23 tables and 100 figures, this 260-page report “Worldwide Influenza Vaccines Market Size, Share, Analysis, Growth, Trends, and Forecast to 2027” is based on a comprehensive research of the worldwide influenza vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the worldwide influenza vaccines market. The report provides historical market data for 2013 – 2019, and forecasts from 2020 until 2027. A comprehensive analysis has been done on market share with the percentage of all the segments.

The report contains a deep analysis of the worldwide influenza vaccines market with size in terms of both value and volume. The report provides a clear insight into current and future developments of the worldwide influenza vaccines market. The report also explores a detailed analysis of the children and adults vaccinated with influenza vaccines worldwide from 2013 to 2019 and forecasts to 2027. It provides essential insights into influenza vaccines market revenue for the top 21 regional and national, and forecast until 2027.

Key trends in terms of collaboration deals, merger & acquisitions, distribution, exclusive and licensing agreement are analyzed with details. The report also offers detailed information about the recruiting clinical trials statement by phase, trial status, study sponsor name and study phase. The report also investigates detailed insights about regulatory landscape including the approval process and an overview of the regulatory authorities in the United States, EU, and Japan. The report also delivers a detailed assessment of the latest happenings in the influenza vaccines market worldwide. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2027.

The report concludes with the profiles of the key players in the worldwide influenza vaccines market. The key players are evaluated on various parameters such as business overview, vaccines portfolio, promising vaccines in the clinical development, influenza vaccines sales value analysis, and recent development.

Other emerging players are making novel technology-based vaccines that are likely to affect the market share during the forecast period. The emerging players are evaluated on various parameters such as business overview, promising vaccines in the clinical development with phase, platform technology, and recent development.

The Report Analyses the Market Based on Countries and Presents the Forecast in Terms of Value and Volume for the Next Seven Years. Countries Covered in the Report Include:

  • United States
  • Canada
  • Brazil
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Netherlands
  • Sweden
  • Denmark
  • Poland
  • Norway
  • Finland
  • Ireland
  • Belgium
  • Australia
  • New Zealand
  • Japan
  • China
  • India

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

  • Sanofi Pasteur
  • GlaxoSmithKline (GSK)
  • Seqirus (CSL Limited)
  • AstraZeneca
  • Mylan
  • Gamma Vaccines Pty Ltd.
  • Hualan Biological Engineering Inc.
  • Shanghai Institute of Biological Products Co., Ltd.
  • BioDiem
  • Novavax
  • BiondVax Pharmaceuticals Ltd.
  • Medicago
  • Moderna Inc
  • Pneumagen
  • Daiichi–Sankyo
  • Altimmune
  • FluGen
  • Imutex

Report Scope:

  • The Market Size of the Worldwide Influenza Vaccines Market with Seven Years Forecast
  • The Market Size of the Regional and National Influenza Vaccines Market with Seven Years Forecast
  • Scrutinizes the Worldwide Overall Persons Being Vaccinated with Influenza Vaccines
  • Scrutinizes the Regional and National Persons Being Vaccinated with Influenza Vaccines
  • Delivers a Latest Happenings in the Worldwide Influenza Vaccines Market
  • Detailed Insights of the Regulatory Framework Including the Approval Process and an Overview of the Regulatory Authorities in the United States, EU, and Japan
  • Provides Key Trends with Respect to Collaboration Deals, Merger & Acquisitions, Distribution, Exclusive and Licensing Agreement
  • Reviews Most Recent Clinical Trials of the Influenza Vaccines
  • A Comprehensive List of the Key Players Along with the Analysis of their Current Vaccines Portfolios, Promising Vaccines in the Clinical Development, Sales Value Analysis, and Recent Development
  • An Insightful Analysis of the Emerging Players Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent Development

The Report Helps Answer the Following Questions:

  • What is the current size of the worldwide influenza vaccines market? How much will this market be worth from 2020 to 2027?
  • How many persons being vaccinated with influenza vaccines worldwide during 2013 – 2027?
  • Which country is expected to hold the highest market share in the worldwide influenza vaccine market?
  • What are the main drivers and restraints in the worldwide influenza vaccines market?
  • What are the major deals happenings in the worldwide influenza vaccines market?
  • Who are the top players and what are their activities, revenue, recent developments, and prospects?
  • What are some of the most prominent influenza vaccines currently in development? What are their activities, phase, platform technology, and recent developments?

The report is readily available and can be dispatched immediately after payment confirmation.

More Information @
https://dpiresearch.com/reports/worldwide-influenza-vaccines-market-size-share-analysis-growth-trends-and-forecast-to-2027/

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact Us:
Maria Rai
Head of Business Development
DPI Research | Web:   https://dpiresearch.com
Direct Line: +91-766-764-8693
E-mail: sales@dpiresearch.com